department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Zydus Therapeutics Inc · pharmadog

PUBLIC COMPANY

Zydus Therapeutics Inc

updated 1mo ago

community read0 votes

pipeline

3

marketed

1

phase 3

1

catalysts ytd

20

approvals ytd

20

recalls ytd

0

Pipeline(3)

pipeline depth3 products

1Phase 31Marketed1Unknown

CEVIMELINE HYDROCHLORIDE

saroglitazar magnesium

Primary Biliary Cholangitis (Primary Biliary Cirrhosis)

DIROXIMEL FUMARATE

Upcoming

no upcoming catalysts on record

Recent(90d)

approval (2)

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Zydus Therapeutics Inc jobs →

News

no news has mentioned this company yet

identifiers

source

globaldata

top tags

mentioned in

0news items

entity-linker matched

BOSENTAN — FDA approval

Zydus Therapeutics Inc

BOSENTAN — FDA approval

Zydus Therapeutics Inc

Data sources

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Active trials

phase3Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapynot yet recruitingn=89
phase3Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomesnot yet recruitingn=386
phase1Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Diseaserecruitingn=30
phase3Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitisrecruitingn=150
phase2Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosisactive not recruitingn=240
phase2Saroglitazar Magnesium 4 mg in the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Women With PCOS (EVIDENCES VII)terminatedn=60
phase2Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With Fibrosiscompletedn=189
phase1Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Diseaserecruitingn=6

more trials →